Inhibikase Therapeutics, Inc. (IKT)
NASDAQ
$2.23+5.69%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 1,071,900
- 52-week high
- —
- 52-week low
- —
- Open
- $2.15
- Day high
- $2.26
- Day low
- $2.11
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$48.26M | -$0.49 |
| 2024 | $0 | -$27.52M | -$1.16 |
| 2023 | $260.5K | -$19.03M | -$3.16 |
| 2022 | $123.44K | -$18.05M | -$4.28 |
| 2021 | $3.1M | -$14.79M | -$0.81 |
About Inhibikase Therapeutics, Inc.
A company overview for Inhibikase Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Inhibikase Therapeutics, Inc.'s stock price today?
- IKT is trading at $2.23 as of Jul 20, 2026.
- Does Inhibikase Therapeutics, Inc. pay a dividend?
- Inhibikase Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.